OraSure Technologies, Inc.
NASDAQ:OSURMedical - Instruments & Supplies
-$0.16 today
- Market cap
- $247.88M
- Beta
- 1.01
- P/E (TTM)
- -4.0
- EPS (TTM)
- -$1.08
Volume 0.49M
Average 0.61M
OSUR Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
OraSure Technologies, Inc.NASDAQ: OSUR
Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Financing cash flow growth accelerates
Q1 FY2026 financing cash flow of $6.28M (cash outflow) rose 559.2% year over year, ahead of the +481.2% change in trailing-twelve-month financing cash flow. Sequentially, it rose 22.8% from the prior quarter. Over 3 fiscal years it compounded at -83.6% a year.
Context
- Financing cash flow amounted to 0.0% of revenue in FY2025, down 2.2 pp from a year earlier.
- Financing cash flow grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +559.2% holds above the trailing-twelve-month pace of +481.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (16.94K) USD
- Year-over-year change
- +99.6%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (16.94K) | +99.6% |
| FY2024 | 2024-12-31 | (4.18M) | -38.1% |
| FY2023 | 2023-12-31 | (3.02M) | +21.0% |
| FY2022 | 2022-12-31 | (3.83M) | -35.9% |
| FY2021 | 2021-12-31 | (2.82M) | — |
Financing Cash Flow vs competitors
How OSUR compares with its peers on the latest reported figures
- Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +481.2% is the highest of 8, against a peer median of -7.2%.
- Financing cash flow amounts to 19.7% of revenue for OSUR, versus a peer median of 124.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $164.7M USD | +23.8% | +468.8% | 26649.8% | |
| LTM Mar 2026 | $82.13M USD | -42.0% | — | — | |
| LTM Mar 2026 | $42.24M USD | +23.6% | +81.2% | 223.8% | |
| LTM Mar 2026 | €38.51M EUR | -50.0% | — | 236.0% | |
| LTM Mar 2026 | $24.27M USD | — | -36.0% | 21.3% | |
| LTM Mar 2026 | $22.27M USD | +481.2% | -83.6% | 19.7% | |
| LTM Mar 2026 | $16.91M USD | — | — | — | |
| LTM Mar 2026 | $11.3M USD | -7.2% | +457.4% | 7.4% | |
| LTM Mar 2026 | $9.22M USD | -61.7% | +31.0% | 24.6% | |
| LTM Mar 2026 | $1.3M USD | +41.9% | -27.5% | — | |
| Peer median (excluding OSUR) | — | -7.2% | +56.1% | 124.2% | |
Competitors are the stored peer set for OSUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (23M) | (17.93M) | 53.66M | (19.5M) | (68.73K) |
| Depreciation & Amortization | 12.5M | 15.54M | 20.94M | 10.87M | 10.19K |
| Deferred Income Tax | 1.03M | (1.65M) | 102K | (657K) | (103) |
| Stock-Based Compensation | 7.81M | 11.62M | 10.73M | 11.92M | 10.15K |
| Change in Working Capital | (38.44M) | (70.56M) | 45.76M | 18.82M | (6.8M) |
| Accounts Receivables | (6.45M) | (25.16M) | 31.12M | 15.87M | 1.95M |
| Inventory | (27.94M) | (43.05M) | 48.23M | 13.1M | 3.56M |
| Accounts Payables | 3.23M | 3.96M | (26.98M) | (7.58M) | (1.72M) |
| Other Working Capital | (7.28M) | (6.32M) | (6.61M) | (2.57M) | (10.59M) |
| Other Non-Cash Items | 4.72M | 15.79M | 10.4M | 5.92M | 6.8M |
| Operating Cash Flow | (35.38M) | (47.2M) | 141.58M | 27.37M | (49.02K) |
| Capital Expenditures | (48.12M) | (63.91M) | (10.3M) | (3.8M) | (4.2K) |
| Acquisitions (Net) | 0 | 121K | 0 | (5.04M) | (3.61K) |
| Purchases of Investments | (25.82M) | (22.87M) | (74.65M) | (53.24M) | 0 |
| Sales of Investments | 67.93M | 47.42M | 102.44M | 53.05M | 0 |
| Other Investing Activities | 513K | 60.33M | 48.67M | (30M) | 1K |
| Investing Cash Flow | (5.5M) | 21.09M | 66.15M | (39.03M) | (6.81K) |
| Debt Repayment | (686K) | (1.38M) | (1.35M) | (842K) | (61K) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (2.11M) | (2.25M) | (1.9M) | (3.55M) | (15.04M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (18K) | (193K) | 223K | 214K | 15.08M |
| Financing Cash Flow | (2.82M) | (3.83M) | (3.02M) | (4.18M) | (16.94K) |
| Effect of Forex Changes | (340K) | (2.84M) | 1.71M | (6.82M) | 4.29K |
| Net Change in Cash | (44.04M) | (32.78M) | 206.43M | (22.64M) | (68.49K) |
| Free Cash Flow | (83.5M) | (111.11M) | 131.28M | 23.58M | (53.22K) |
OraSure Technologies, Inc.
NASDAQ:OSUR
Intrinsic Alpha fair value
Locked
Current Price
$3.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.